IBT

IBT (Infinite Biomedical Technologies, LLC) is a minority-owned medical device and translational research company based in Baltimore, Maryland. Founded in 1997, IBT aims to enhance the lives of individuals with upper limb loss by developing innovative prosthetic devices and control systems. The company originated from Johns Hopkins School of Medicine and has a strong focus on bridging laboratory research with practical medical applications. IBT specializes in advanced upper limb prosthetic solutions, including the Glide myoelectric control system, which personalizes the control of prostheses, and the FlexCell battery system designed for prosthetic use. With over 50 peer-reviewed publications, 9 patents, and 55 awarded grants, IBT has served more than 5,000 patients and distributes its products in 21 countries. The company offers services in translational research, product development, and manufacturing, supported by a dedicated team of engineers and marketing professionals. IBT is committed to providing high-functionality medical devices that meet the needs of hospitals, clinics, and individuals seeking advanced prosthetic solutions.

• Employees58
• Founded1997
• Annual Revenue$6261000